ERCC1 and ERCC2 Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-Analysis

Clinical Cancer Research - United States
doi 10.1158/1078-0432.ccr-10-2169

Related search